EDAP Reports First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
H.C. Wainwright Reiterates Buy Rating on EDAP TMS S.A. (EDAP)
May 17, 2024 1:52 PM EDTH.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $19.00 price target on EDAP TMS S.A. (NASDAQ: EDAP)
The analyst comments "Robust increase in procedure volume and steady progress in system placement. EDAP reported HIFU-related revenue of 5.8M in 1Q24, a 10% YoY increase from 5.3M in 1Q23. The revenue growth was driven mainly by a 92% YoY increase in procedure volume, which we believe reflects strong adoption growth among urologists. Looking ahead, we believe that recently presented positive... More
